Expanded Access Study of Exebacase in COVID-19 Patients With Persistent MRSA Bacteremia

NCT04597242 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

MRSA Bloodstream Infection
MRSA Bacteremia
MRSA Right-sided Endocarditis
Covid19

Interventions

DRUG: Exebacase

Sponsor

ContraFect